← back to search
Jingfeng Li
The Ohio State University
· US
Area of research
Molecular Biology · Plant Science
Research interest
Research interests include Programmed cell death, Doxorubicin, Autophagy, Cancer research, and Apoptosis.
h-index
—
citations
13
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death
Frontiers in Oncology
2021
cited by
13
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Ming Shao
· Kunming University of Science and Technology
1
papers (2021–2021)
Jiang Xu
· Shihezi University
1
papers (2021–2021)
Man‐Sun Sy
· Case Western Reserve University
1
papers (2021–2021)
Zhenxing Gao
· Guangzhou Medical University
1
papers (2021–2021)
Guiru Wu
· Guangzhou Medical University
1
papers (2021–2021)
Run Shi
· Southwest University
1
papers (2021–2021)
Shanshan Gao
· Ministry of Education of the People's Republic of China
1
papers (2021–2021)
Shuzhong Cui
· Guangzhou Medical University
1
papers (2021–2021)
Tian-Yun Chen
· Nanchang University
1
papers (2021–2021)
Weimin Hu
· Shanghai University
1
papers (2021–2021)
Huan Li
· Virginia Tech
1
papers (2021–2021)
Jie Zhang
· Shenzhen Center for Disease Control and Prevention
1
papers (2021–2021)
Chaoyang Li
· Shandong University
1
papers (2021–2021)